Alnylam Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. 

CEO
Yvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees
2,230
Employees2,230
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2002
Founded2002
Employees
2,230
Employees2,230

ALNY Key Statistics

Market cap
41.37B
Market cap41.37B
Price-Earnings ratio
-151.70
Price-Earnings ratio-151.70
Dividend yield
—
Dividend yield—
Average volume
1.02M
Average volume1.02M
High today
$328.99
High today$328.99
Low today
$316.19
Low today$316.19
Open price
$324.13
Open price$324.13
Volume
968.53K
Volume968.53K
52 Week high
$333.70
52 Week high$333.70
52 Week low
$205.87
52 Week low$205.87

Analyst ratings

71%

of 34 ratings
Buy
70.6%
Hold
26.5%
Sell
2.9%

People also own

Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.
Eli Lilly
Netflix
Vertex Pharmaceuticals
CrowdStrike Holdings
Moderna
Taiwan Semiconductor Manu…
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.